Dynacure S.A. (DYCU)
Dynacure was planning to go public, but the IPO has been withdrawn.
Stock Price: $15.00 - $17.00
Current IPO price range
Chart not available yet
Data will show when the stock starts trading.
| Market Cap | 314.81M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -18.57M |
| Shares Out | 19.68M |
| EPS (ttm) | -0.94 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About DYCU
Dynacure S.A. is a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. We are initially focused on developing treatments for neuromuscular diseases, beginning with myotubular and centronuclear myopathies, or CNM, a group of devastating rare genetic disorders characterized by severe muscle weakness, or myopathy, with shortened life expectancy and significant morbidity. Our lead product candidate, DYN101, is an antisense ol... [Read more...]
Industry
Pharmaceutical Preparations
Founded
2016
CEO
Stéphane van Rooijen, M.D, M.B.A.
Employees
22
Stock Exchange
NASDAQ
Ticker Symbol
DYCU
News
Dynacure S.A. IPO Registration Document (S-1)
Dynacure S.A. has filed to go public with an IPO on the NASDAQ.